BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25783213)

  • 1. [Molecular diagnostics in melanoma].
    Lang R; Bauer JW; Laimer M
    Hautarzt; 2015 Apr; 66(4):277-81. PubMed ID: 25783213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular and immunohistochemical diagnostics in melanoma].
    Schilling B; Griewank KG
    Hautarzt; 2016 Jul; 67(7):511-8. PubMed ID: 27270408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular diagnosis of melanocytic tumors].
    Bauer J
    Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis in malignant melanoma.
    Gaiser MR; Stadler R; Schirmacher P; Dietel M; Enk A
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():2-10. PubMed ID: 23721634
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular biology methods to improve diagnosis and prognosis of melanocytic tumors.
    Wiesner T; Fried I; Cerroni L; Kutzner H
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():19-24. PubMed ID: 23721637
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular diagnosis of melanoma-have we arrived?
    Bordelon JR; Grichnik JM
    Dermatol Ther; 2015; 28(6):405. PubMed ID: 26031627
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetics of melanoma predisposition.
    Lin J; Hocker TL; Singh M; Tsao H
    Br J Dermatol; 2008 Aug; 159(2):286-91. PubMed ID: 18547303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for familial melanoma: recommendations from a national centre of expertise.
    Halk AB; Potjer TP; Kukutsch NA; Vasen HFA; Hes FJ; van Doorn R
    Br J Dermatol; 2019 Sep; 181(3):594-596. PubMed ID: 30742720
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hereditary cutaneous tumor syndromes].
    Hermasch MA; Frank J
    Hautarzt; 2019 Jul; 70(7):490-496. PubMed ID: 31143971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of genomics on the surgical management of melanoma.
    Ferguson PM; Long GV; Scolyer RA; Thompson JF
    Br J Surg; 2018 Jan; 105(2):e31-e47. PubMed ID: 29341162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple primary melanomas versus single melanoma of the head and neck: a comparison of genetic, diagnostic, and therapeutic implications.
    Pollio A; Tomasi A; Pellacani G; Ruini C; Mandel VD; Fortuna G; Seidenari S; Ponti G
    Melanoma Res; 2014 Jun; 24(3):267-72. PubMed ID: 24638154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of familial melanoma and nonmelanoma skin cancer syndromes.
    Santillan AA; Cherpelis BS; Glass LF; Sondak VK
    Surg Oncol Clin N Am; 2009 Jan; 18(1):73-98, viii. PubMed ID: 19056043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling in melanoma: past results and future potential.
    Knackstedt RW; Knackstedt T; Gastman B
    Future Oncol; 2019 Mar; 15(7):791-800. PubMed ID: 30453756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular aspects of melanoma.
    Da Forno PD; Saldanha GS
    Clin Lab Med; 2011 Jun; 31(2):331-43. PubMed ID: 21549246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular diagnostics of melanomas].
    Griewank KG
    Pathologe; 2015 Feb; 36(1):30-6. PubMed ID: 25491471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches.
    March J; Hand M; Truong A; Grossman D
    J Am Acad Dermatol; 2015 Jun; 72(6):943-58; quiz 959-60. PubMed ID: 25980999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation Testing and Adjuvant Systemic Therapy in Cutaneous Melanoma.
    Olszanski AJ
    J Natl Compr Canc Netw; 2019 May; 17(5.5):615-617. PubMed ID: 31117032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnostics in melanoma: current status and perspectives.
    Dadras SS
    Arch Pathol Lab Med; 2011 Jul; 135(7):860-9. PubMed ID: 21732775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective amplification of rare mutations using locked nucleic acid oligonucleotides that competitively inhibit primer binding to wild-type DNA.
    Oldenburg RP; Liu MS; Kolodney MS
    J Invest Dermatol; 2008 Feb; 128(2):398-402. PubMed ID: 17581615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic classification of difficult melanocytic tumors.
    Metzler G; Eigentler TK; Held L; Kind P; Hantschke M; Garbe C; Bauer J
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():11-8. PubMed ID: 23721635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.